Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Equity: 2011-2025

Historic Return on Equity for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Sep 2025 value amounting to 0.24%.

  • Catalyst Pharmaceuticals' Return on Equity rose 4.00% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 4.00%. This contributed to the annual value of 0.29% for FY2024, which is 12.00% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Return on Equity stood at 0.24% for Q3 2025, which was down 3.12% from 0.25% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Return on Equity's 5-year high stood at 0.41% during Q1 2021, with a 5-year trough of 0.10% in Q2 2024.
  • In the last 3 years, Catalyst Pharmaceuticals' Return on Equity had a median value of 0.24% in 2024 and averaged 0.22%.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Return on Equity slumped by 32bps in 2021 and then climbed by 16bps in 2025.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Return on Equity stood at 0.19% in 2021, then grew by 10bps to 0.29% in 2022, then decreased by 13bps to 0.16% in 2023, then increased by 7bps to 0.24% in 2024, then rose by 4bps to 0.24% in 2025.
  • Its Return on Equity was 0.24% in Q3 2025, compared to 0.25% in Q2 2025 and 0.26% in Q1 2025.